1 year return (CAGR)
48.08%
Inhibikase Therapeutics Inc Exchange (NASDAQ, USD)
IKT
2.31
-0.08 (-3.35%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
4.57%
5 year return (CAGR)
-30.82%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
322.33M
Price/Sales
-
Ent value
301.38M
Price/Book
2.10
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-25.09%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.40 |
| Daily high | 2.40 |
| Daily low | 2.25 |
| Daily Volume | 481K |
| All-time high | 58.80 |
| 1y analyst estimate | 6.00 |
| Beta | 0.95 |
| EPS (TTM) | -0.35 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| IKT | S&P500 | |
| Current price drop from All-time high | -96.07% | -2.63% |
| Highest price drop | -98.62% | -56.47% |
| Date of highest drop | 9 Oct 2023 | 9 Mar 2009 |
| Avg drop from high | -88.57% | -10.68% |
| Avg time to new high | 718 days | 12 days |
| Max time to new high | 1436 days | 1805 days |
News
